-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Severe visual loss associated with idiopathic intracranial hypertension (IIH) in pregnancy
(2419) Views (544) Full article downloads
Authors: Katherine J Zamecki, Larry P Frohman, Roger E Turbin
Published Date October 2007
Volume 2007:1(2) Pages 99 - 103
DOI: http://dx.doi.org/10.2147/OPTH.S
Katherine J Zamecki1, Larry P Frohman1,2, Roger E Turbin1,2
1University of Medicine and Dentistry, New Jersey Medical School, Newark, NJ; 2Department of Ophthalmology, Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, NJ, USA
Abstract: Idiopathic intracranial hypertension (IIH) in pregnancy is often responsive to conservative management and usually carries a favorable prognosis. Pregnant patients may be managed with dietary control, corticosteroid therapy, diuretics, and occasionally serial lumbar puncture. We report an unusual case of permanent visual loss due to IIH in pregnancy, requiring aggressive CSF diversion and bilateral optic nerve sheath fenestration after failure to improve with a brief course of medical management and a lumbar puncture. Despite resolution of the papilledema, the subject’s acuity improved only to 20/40 in the right eye and remained no light perception in the left eye.
Keywords: idiopathic intracranial hypertension, pregnancy, visual loss
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia
- Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%




